Regeneron Pharmaceuticals Inc (REGN)
881.12
-9.56
(-1.07%)
USD |
NASDAQ |
Apr 26, 11:30
Regeneron Pharmaceuticals Market Cap: 96.71B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 97.76B |
| April 24, 2024 | 99.50B |
| April 23, 2024 | 99.59B |
| April 22, 2024 | 98.80B |
| April 19, 2024 | 98.44B |
| April 18, 2024 | 98.13B |
| April 17, 2024 | 98.92B |
| April 16, 2024 | 98.14B |
| April 15, 2024 | 98.63B |
| April 12, 2024 | 99.30B |
| April 11, 2024 | 101.02B |
| April 10, 2024 | 102.76B |
| April 09, 2024 | 103.60B |
| April 08, 2024 | 103.01B |
| April 05, 2024 | 103.47B |
| April 04, 2024 | 102.85B |
| April 03, 2024 | 104.38B |
| April 02, 2024 | 104.79B |
| April 01, 2024 | 106.39B |
| March 28, 2024 | 105.64B |
| March 27, 2024 | 106.06B |
| March 26, 2024 | 105.76B |
| March 25, 2024 | 105.49B |
| March 22, 2024 | 106.17B |
| March 21, 2024 | 106.25B |
| Date | Value |
|---|---|
| March 20, 2024 | 106.14B |
| March 19, 2024 | 105.77B |
| March 18, 2024 | 105.36B |
| March 15, 2024 | 105.86B |
| March 14, 2024 | 105.27B |
| March 13, 2024 | 105.97B |
| March 12, 2024 | 106.53B |
| March 11, 2024 | 105.86B |
| March 08, 2024 | 106.34B |
| March 07, 2024 | 106.83B |
| March 06, 2024 | 106.70B |
| March 05, 2024 | 105.94B |
| March 04, 2024 | 106.60B |
| March 01, 2024 | 107.88B |
| February 29, 2024 | 106.04B |
| February 28, 2024 | 108.40B |
| February 27, 2024 | 109.03B |
| February 26, 2024 | 108.59B |
| February 23, 2024 | 107.70B |
| February 22, 2024 | 105.91B |
| February 21, 2024 | 104.59B |
| February 20, 2024 | 103.93B |
| February 16, 2024 | 104.06B |
| February 15, 2024 | 104.79B |
| February 14, 2024 | 104.03B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
30.03B
Minimum
Sep 27 2019
109.03B
Maximum
Feb 27 2024
66.26B
Average
66.06B
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 102.70B |
| Eli Lilly and Co | 699.21B |
| AbbVie Inc | 283.87B |
| Amgen Inc | 144.56B |
| Pfizer Inc | 143.40B |
Market Cap Related Metrics
| PE Ratio | 25.36 |
| PS Ratio | 7.641 |
| Price to Book Value | 3.724 |
| Price to Free Cash Flow | 27.33 |
| Price | 881.12 |
| Earnings Yield | 3.94% |
| Operating PE Ratio | 23.68 |
| Normalized PE Ratio | 22.98 |